F/m Emerald Life Sciences... (LFSC)
NasdaqGM: LFSC
· Precio en tiempo real · USD
47.30
+0.38 (0.81%)
Al cierre: Aug 12, 2026, 12:07 PM
F/m Emerald Life Sciences Innovation ETF (LFSC) ETF Price, Holdings & Analysis
0.81% (1D)
| Precio de compra | 47.25 |
| Capitalización de mercado | n/a |
| AUM | 124.88M |
| NAV | 47.39 |
| Beta | n/a |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | Oct 30, 2024 |
| Precio de venta | 47.58 |
| Volumen | 2,101 |
| Volumen medio (20D) | 4,538 |
| Abierto | 47.12 |
| Cierre anterior | 46.92 |
| Rango del día | 47.10 - 47.30 |
| Rango de 52 semanas | 26.75 - 47.68 |
| Participaciones | n/a |
| Relación de gastos | 0.54% |
Acerca de LFSC
The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Clase de activo Equity
Símbolo bursátil LFSC
Fecha de inicio Oct 30, 2024
Proveedor Emerald Mutual Fund Advisers Trust
Sitio web Página de inicio del fondo
Intercambio NasdaqGM
Las 10 principales participaciones 57.58% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Travere Therapeutics... | TVTX | 7.84% |
| Spyre Therapeutics I... | SYRE | 7.40% |
| Cogent Biosciences I... | COGT | 7.23% |
| Corcept Therapeutics... | CORT | 6.82% |
| Livanova PLC | LIVN | 6.67% |
| Guardant Health Inc | GH | 5.95% |
| Billiontoone Inc Ord... | BLLN | 4.91% |
| Cytokinetics Inc | CYTK | 3.82% |
| Mirum Pharmaceutical... | MIRM | 3.58% |
| Axsome Therapeutics ... | AXSM | 3.36% |
